1. Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc Soc Exp Biol Med. 1999; 222:99–112.
2. Sherlock S. Hepatic encephalopathy. Br J Hosp Med. 1977; 17:144–159. 144-6, 151-4, 159.
3. Inoue E, Hori S, Narumi Y, Fujita M, Kuriyama K, Kadota T, et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology. 1991; 179:551–5.
4. Syh HW, Chu WK, Mar N, McConnell JR. An image analysis on MR imaging of the brain for hepatic encephalopathy. Biomed Sci Instrum. 1991; 27:29–33.
5. Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn Reson Imaging. 1991; 9:295–302.
6. Zerón HM, Rodríguez MR, Montes S, Castañeda CR. Blood manganese levels in patients with hepatic encephalopathy. J Trace Elem Med Biol. 2011; 25:225–9.
7. Pujol A, Pujol J, Graus F, Rimola A, Peri J, Mercader JM, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology. 1993; 43:65–9.
8. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270–4.
9. Lee DH, Lee HJ, Hahm MH. The pallidal index in patients with acute-on-chronic liver disease: is it a predictor of severe hepatic encephalopathy? Investig Magn Reson Imaging. 2017; 21:125–30.
10. Rovira A, Córdoba J, Sanpedro F, Grivé E, Rovira-Gols A, Alonso J. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology. 2002; 59:335–41.
11. Gabriel S, Grossmann A, Höppner J, Benecke R, Rolfs A. Marchiafava-Bignami syndrome: extrapontine myelinolysis in chronic alcoholism. Nervenarzt. 1999; 70:349–56.
12. Alvarez-Leal M, Contreras-Hernández D, Chávez A, Diaz-Contreras JA, Careaga-Olivares J, Zúñiga-Charles MA, et al. Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis. Am J Hum Biol. 2001; 13:297–300.
13. Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol. 2008; 29:1612–21.
14. Arnold SM, Els T, Spreer J, Schumacher M. Acute hepatic encephalopathy with diffuse cortical lesions. Neuroradiology. 2001; 43:551–4.
15. Matsusue E, Kinoshita T, Ohama E, Ogawa T. Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. AJNR Am J Neuroradiol. 2005; 26:347–51.
16. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology. 1992; 182:19–27.
17. Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, et al. Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys. 2006; 7:86–96.
18. Binesh N, Huda A, Bugbee M, Gupta R, Rasgon N, Kumar A, et al. Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy. J Magn Reson Imaging. 2005; 21:398–405.
19. Taylor-Robinson SD, Sargentoni J, Oatridge A, Bryant DJ, Hajnal JV, Marcus CD, et al. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis. 1996; 11:249–68.
20. Butterworth R. Neuronal cell death in hepatic encephalopathy. Metab Brain Dis. 2007; 22:309–20.
21. Norenberg MD, Bender AS. Astrocyte swelling in liver failure: role of glutamine and benzodiazepines. Acta Neurochir Suppl (Wien). 1994; 60:24–7.
22. Kril JJ, Butterworth RF. Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. Hepatology. 1997; 26:837–41.
23. Kreis R, Farrow N, Ross BD. Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy: analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed. 1991; 4:109–16.
24. Romero-Gómez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol. 2015; 62:437–47.
25. Victor M, Adams RD, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore). 1965; 44:345–96.
26. Sobel RA, DeArmond SJ, Forno LS, Eng LF. Glial fibrillary acidic protein in hepatic encephalopathy: an immunohistochemical study. J Neuropathol Exp Neurol. 1981; 40:625–32.
27. Butterworth RF, Giguère JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol. 1987; 6:1–12.
28. Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology. 1992; 15:1060–6.
29. Desjardins P, Bélanger M, Butterworth RF. Alterations in expression of genes coding for key astrocytic proteins in acute liver failure. J Neurosci Res. 2001; 66:967–71.
30. Rama Rao KV, Chen M, Simard JM, Norenberg MD. Suppression of ammonia-induced astrocyte swelling by cyclosporin A. J Neurosci Res. 2003; 74:891–7.
31. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002; 35:716–21.
32. Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio O. Hepatic encephalopathy: diagnosis and management. J Transl Int Med. 2020; 8:210–9.
33. Häussinger D, Schliess F, Kircheis G. Pathogenesis of hepatic encephalopathy. J Gastroenterol Hepatol. 2002; 17(Suppl 3):S256–9.
34. Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif. 2002; 20:252–61.
35. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013; 144:1426–37.
36. Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020; 382:2137–45.
37. Kleinschmidt-DeMasters BK, Filley CM, Rojiani AM. Overlapping features of extrapontine myelinolysis and acquired chronic (non-Wilsonian) hepatocerebral degeneration. Acta Neuropathol. 2006; 112:605–16.
38. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959; 81:154–72.
39. Ho VB, Fitz CR, Yoder CC, Geyer CA. Resolving MR features in osmotic myelinolysis (central pontine and extrapontine myelinolysis). AJNR Am J Neuroradiol. 1993; 14:163–7.
40. Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol. 1987; 6:262–70.
41. Kim E, Na DG, Kim EY, Kim JH, Son KR, Chang KH. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol. 2007; 28:1652–8.
42. Behzadi F, Fiester PJ, Rao D. Bilateral hypertrophic olivary degeneration following brainstem insult: a retrospective review and examination of causative pathology. Neurosci Insights. 2021; 16:26331055211007445.
43. Jang S, Suh SI, Ha SM, Byeon JH, Eun BL, Lee YH, et al. Enterovirus 71-related encephalomyelitis: usual and unusual magnetic resonance imaging findings. Neuroradiology. 2012; 54:239–45.
44. Di Rocco M, Biancheri R, Rossi A, Allegri AE, Vecchi V, Tortori-Donati P. MRI in acute intermittent maple syrup urine disease. Neurology. 2004; 63:1078.
45. Geyer HL, Schaumburg HH, Herskovitz S. Methyl bromide intoxication causes reversible symmetric brainstem and cerebellar MRI lesions. Neurology. 2005; 64:1279–81.